Stroke Clinical Trials

Find Stroke Clinical Trials Near You

Emergent Large Vessel Occlusion Endovascular Rescue Therapy With Underlying Intracranial Stenosis

Status: Recruiting
Location: See location...
Intervention Type: Device, Procedure
Study Type: Interventional
Study Phase: Phase 3
SUMMARY

The study objective is to establish the safety and efficacy of endovascular adjunct stenting for patients undergoing mechanical thrombectomy (MT) that are found to have residual stenosis (70-99%) following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• 18 to 80 years of age

• Presenting with symptoms consistent with AIS

• Imaging evidence of an anterior occlusion of the Internal Carotid Artery (ICA) or Middle Cerebral Artery Main Stem (MCA M1), or proximal M2 segment AND residual 70-99% stenosis of the index artery following attempted clot retrieval with either aspiration catheters or stent retrievers, per device instructions for use and device labeling

• NIHSS ≥ 6

• Ability to randomize within 24 hours of stroke onset.

• Pre-stroke mRS score 0-2

• Ability to obtain signed informed consent.

• ASPECTS Score ≥ 6 by non-contrast CT scan

• Score-ICAD score of ≥11 points at screening and/or persistent stenotic occlusion of ≥70% after MT

⁃ If indicated, thrombolytic therapy shall be initiated per the institution's usual care and the most recent version of the AHA/ASA Guidelines. Subjects eligible for IV thrombolysis should receive it without delay.

⁃ For subjects presenting \>6 hours from stroke onset, infarct core volume \<50 cc quantified by CTP

Locations
United States
Ohio
ProMedica Toledo Hospital
RECRUITING
Toledo
Contact Information
Primary
Sami Al Kasab, MD
alkasab@musc.edu
4192913498
Backup
Mouhammad Jumaa, MD
Mouhammad.JumaaMD@ProMedica.org
Time Frame
Start Date: 2026-05-19
Estimated Completion Date: 2030-06-01
Participants
Target number of participants: 342
Treatments
Experimental: Randomized to Mechanical Thrombectomy (MT) plus adjunct Stenting
Patients will have mechanical thrombectomy (MT) and stenting
Active_comparator: Randomized to Mechanical Thrombectomy (MT)
Patients will only have mechanical thrombectomy (MT) done
Related Therapeutic Areas
Sponsors
Leads: ProMedica Health System

This content was sourced from clinicaltrials.gov